Akhila Md Mba Alapati
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Akhila Md Mba Alapati has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Anjum Koreishi
Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
2 shared publicationsKevin Zhang
Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
2 shared publicationsSaleema Kherani
Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
2 shared publicationsTedi Begaj
Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
2 shared publications- Adda L. Villanueva
Affiliations Retina and Genomics Institute, Yucatán, México, Laboratoire de Diagnostic Moleculaire, Hôpital Maisonneuve Rosemont, Montreal, Quebec, Canada
1 shared publication - Andrew Huynh
Affiliation Shiley Eye Institute, University of California San Diego, La Jolla, California, United States of America
1 shared publication
Latest Publications
- 1 August 2025
- Published by Wolters Kluwer Health in Retina
- Vol. 45 (8) , e66-e67
Reply
An abstract is unavailable. This article is available as a PDF only.
- 1 August 2025
- Published by Wolters Kluwer Health in Retina
- Vol. 45 (8) , e66-e67
Reply
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 1 January 2025
- Published by Wolters Kluwer Health in Retina
- Vol. 45 (1) , 147-153
MACULAR VOLUME SCAN AS A MARKER OF ANGIOGRAPHIC UVEITIC RETINAL VASCULITIS
Purpose: To determine whether optical coherence tomography thickness values from macular volume scans can be used to detect uveitic retinal vasculitis. Methods: Retrospective study of patients with noninfectious retinal vasculitis. Fluorescein angiogram and 61-line optical coherence tomography macular volume scans with an overlying Early Treatment Diabetic Retinopathy study grid were obtained. Correlation between 1 mm and 6 mm Early Treatment Diabetic Retinopathy study ring values and posterior pole vasculitis was analyzed. A linear longitudinal model was used to assess the relationship between global retinal vasculitis scores and optical coherence tomography macular thickness parameters. Results: Ninety-nine eyes of 54 patients were included. A total of 460 optical coherence tomography and fluorescein angiogram pairs were analyzed. Central (1 mm) macular thickness was weakly correlated with posterior pole vasculitis (correlation coefficient [rho] = 0.09, P = 0.06). Both the mean 6 mm ring (rho = 0.11, P = 0.018) and the average of the superior and inferior (S/I) 6 mm ring values (rho = 0.13, P = 0.006) were strongly correlated with posterior pole leakage. The longitudinal model showed that S/I 6 mm ring values are associated with vasculitis in the posterior pole, mid, and far periphery (P < 0.0001). Conclusion: Optical coherence tomography–based macular volume thickness can detect uveitic retinal vasculitis and aid in monitoring disease activity.
- 1 January 2025
- Published by Wolters Kluwer Health in Retina
- Vol. 45 (1) , 147-153
Open AccessMACULAR VOLUME SCAN AS A MARKER OF ANGIOGRAPHIC UVEITIC RETINAL VASCULITIS
Purpose: To determine whether optical coherence tomography thickness values from macular volume scans can be used to detect uveitic retinal vasculitis. Methods: Retrospective study of patients with noninfectious retinal vasculitis. Fluorescein angiogram and 61-line optical coherence tomography macular volume scans with an overlying Early Treatment Diabetic Retinopathy study grid were obtained. Correlation between 1 mm and 6 mm Early Treatment Diabetic Retinopathy study ring values and posterior pole vasculitis was analyzed. A linear longitudinal model was used to assess the relationship between global retinal vasculitis scores and optical coherence tomography macular thickness parameters. Results: Ninety-nine eyes of 54 patients were included. A total of 460 optical coherence tomography and fluorescein angiogram pairs were analyzed. Central (1 mm) macular thickness was weakly correlated with posterior pole vasculitis (correlation coefficient [rho] = 0.09, P = 0.06). Both the mean 6 mm ring (rho = 0.11, P = 0.018) and the average of the superior and inferior (S/I) 6 mm ring values (rho = 0.13, P = 0.006) were strongly correlated with posterior pole leakage. The longitudinal model showed that S/I 6 mm ring values are associated with vasculitis in the posterior pole, mid, and far periphery (P < 0.0001). Conclusion: Optical coherence tomography–based macular volume thickness can detect uveitic retinal vasculitis and aid in monitoring disease activity.
- 1 January 2025
- Published by Wolters Kluwer Health in RETINAL Cases & Brief Reports
- Vol. 19 (1) , 10-13
TREATMENT OF SERPIGINOUS CHOROIDITIS WITH SUBTENON TRIAMCINOLONE IN CONJUNCTION WITH SYSTEMIC STEROIDS: A CASE REPORT
Purpose: To report two cases of serpiginous choroiditis which were treated with subtenon triamcinolone in conjunction with systemic steroids to control acute and chronic disease progression. Increased success of disease remission has been postulated for subtenon triamcinolone therapy in conjunction with systemic steroids. Methods: Retrospective chart review of two serpiginous choroiditis patients who presented at an eye center. Both patients received subtenon triamcinolone and systemic steroids. Visual acuity and disease course are reported. Results: Both cases of serpiginous choroiditis received subtenon triamcinolone on presentation and were hospitalized for IV corticosteroids and systemic workup. The first patient had been on oral corticosteroids before presentation. Both patients reported same-day visual improvement after subtenon triamcinolone was administered. Conclusion: These two case reports describe unique clinical scenarios in which subtenon triamcinolone was used in both the acute and chronic phases of serpiginous choroiditis. Local steroid therapy can be a useful adjunctive therapy when systemic steroids are delayed, contraindicated, or intolerable.
- 1 January 2025
- Published by Wolters Kluwer Health in RETINAL Cases & Brief Reports
- Vol. 19 (1) , 10-13
TREATMENT OF SERPIGINOUS CHOROIDITIS WITH SUBTENON TRIAMCINOLONE IN CONJUNCTION WITH SYSTEMIC STEROIDS: A CASE REPORT
Purpose: To report two cases of serpiginous choroiditis which were treated with subtenon triamcinolone in conjunction with systemic steroids to control acute and chronic disease progression. Increased success of disease remission has been postulated for subtenon triamcinolone therapy in conjunction with systemic steroids. Methods: Retrospective chart review of two serpiginous choroiditis patients who presented at an eye center. Both patients received subtenon triamcinolone and systemic steroids. Visual acuity and disease course are reported. Results: Both cases of serpiginous choroiditis received subtenon triamcinolone on presentation and were hospitalized for IV corticosteroids and systemic workup. The first patient had been on oral corticosteroids before presentation. Both patients reported same-day visual improvement after subtenon triamcinolone was administered. Conclusion: These two case reports describe unique clinical scenarios in which subtenon triamcinolone was used in both the acute and chronic phases of serpiginous choroiditis. Local steroid therapy can be a useful adjunctive therapy when systemic steroids are delayed, contraindicated, or intolerable.
- Open Access
- 18 October 2021
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 17 (10) , e1009848
Deciphering the genetic architecture and ethnographic distribution of IRD in three ethnic populations by whole genome sequence analysis
Patients with inherited retinal dystrophies (IRDs) were recruited from two understudied populations: Mexico and Pakistan as well as a third well-studied population of European Americans to define the genetic architecture of IRD by performing whole-genome sequencing (WGS). Whole-genome analysis was performed on 409 individuals from 108 unrelated pedigrees with IRDs. All patients underwent an ophthalmic evaluation to establish the retinal phenotype. Although the 108 pedigrees in this study had previously been examined for mutations in known IRD genes using a wide range of methodologies including targeted gene(s) or mutation(s) screening, linkage analysis and exome sequencing, the gene mutations responsible for IRD in these 108 pedigrees were not determined. WGS was performed on these pedigrees using Illumina X10 at a minimum of 30X depth. The sequence reads were mapped against hg19 followed by variant calling using GATK. The genome variants were annotated using SnpEff, PolyPhen2, and CADD score; the structural variants (SVs) were called using GenomeSTRiP and LUMPY. We identified potential causative sequence alterations in 61 pedigrees (57%), including 39 novel and 54 reported variants in IRD genes. For 57 of these pedigrees the observed genotype was consistent with the initial clinical diagnosis, the remaining 4 had the clinical diagnosis reclassified based on our findings. In seven pedigrees (12%) we observed atypical causal variants, i.e. unexpected genotype(s), including 4 pedigrees with causal variants in more than one IRD gene within all affected family members, one pedigree with intrafamilial genetic heterogeneity (different affected family members carrying causal variants in different IRD genes), one pedigree carrying a dominant causative variant present in pseudo-recessive form due to consanguinity and one pedigree with a de-novo variant in the affected family member. Combined atypical and large structural variants contributed to about 20% of cases. Among the novel mutations, 75% were detected in Mexican and 50% found in European American pedigrees and have not been reported in any other population while only 20% were detected in Pakistani pedigrees and were not previously reported. The remaining novel IRD causative variants were listed in gnomAD but were found to be very rare and population specific. Mutations in known IRD associated genes contributed to pathology in 63% Mexican, 60% Pakistani and 45% European American pedigrees analyzed. Overall, contribution of known IRD gene variants to disease pathology in these three populations was similar to that observed in other populations worldwide. This study revealed a spectrum of mutations contributing to IRD in three populations, identified a large proportion of novel potentially causative variants that are specific to the corresponding population or not reported in gnomAD and shed light on the genetic architecture of IRD in these diverse global populations.
- 18 October 2021
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 17 (10) , e1009848
Open AccessDeciphering the genetic architecture and ethnographic distribution of IRD in three ethnic populations by whole genome sequence analysis
Patients with inherited retinal dystrophies (IRDs) were recruited from two understudied populations: Mexico and Pakistan as well as a third well-studied population of European Americans to define the genetic architecture of IRD by performing whole-genome sequencing (WGS). Whole-genome analysis was performed on 409 individuals from 108 unrelated pedigrees with IRDs. All patients underwent an ophthalmic evaluation to establish the retinal phenotype. Although the 108 pedigrees in this study had previously been examined for mutations in known IRD genes using a wide range of methodologies including targeted gene(s) or mutation(s) screening, linkage analysis and exome sequencing, the gene mutations responsible for IRD in these 108 pedigrees were not determined. WGS was performed on these pedigrees using Illumina X10 at a minimum of 30X depth. The sequence reads were mapped against hg19 followed by variant calling using GATK. The genome variants were annotated using SnpEff, PolyPhen2, and CADD score; the structural variants (SVs) were called using GenomeSTRiP and LUMPY. We identified potential causative sequence alterations in 61 pedigrees (57%), including 39 novel and 54 reported variants in IRD genes. For 57 of these pedigrees the observed genotype was consistent with the initial clinical diagnosis, the remaining 4 had the clinical diagnosis reclassified based on our findings. In seven pedigrees (12%) we observed atypical causal variants, i.e. unexpected genotype(s), including 4 pedigrees with causal variants in more than one IRD gene within all affected family members, one pedigree with intrafamilial genetic heterogeneity (different affected family members carrying causal variants in different IRD genes), one pedigree carrying a dominant causative variant present in pseudo-recessive form due to consanguinity and one pedigree with a de-novo variant in the affected family member. Combined atypical and large structural variants contributed to about 20% of cases. Among the novel mutations, 75% were detected in Mexican and 50% found in European American pedigrees and have not been reported in any other population while only 20% were detected in Pakistani pedigrees and were not previously reported. The remaining novel IRD causative variants were listed in gnomAD but were found to be very rare and population specific. Mutations in known IRD associated genes contributed to pathology in 63% Mexican, 60% Pakistani and 45% European American pedigrees analyzed. Overall, contribution of known IRD gene variants to disease pathology in these three populations was similar to that observed in other populations worldwide. This study revealed a spectrum of mutations contributing to IRD in three populations, identified a large proportion of novel potentially causative variants that are specific to the corresponding population or not reported in gnomAD and shed light on the genetic architecture of IRD in these diverse global populations.